Lite Strategy, Inc.
LSE: 0JW9.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Justin J. File
- Employees
- 28
- Headquarters
- San Diego, United States
- IPO year
- 2018
- Market cap
- $8.0M
- Website
- https://www.litestrategy.com
Loading 0JW9…
Loading profile data…Frequently asked questions about 0JW9
What does Lite Strategy, Inc. (0JW9.L) do?
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors...
Where does 0JW9.L trade?
Lite Strategy, Inc. (0JW9.L) trades on the London Stock Exchange.
What sector is 0JW9.L in?
Lite Strategy, Inc. (0JW9.L) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Lite Strategy, Inc.?
Justin J. File is the chief executive officer of Lite Strategy, Inc. (0JW9.L).
Where is Lite Strategy, Inc. headquartered?
Lite Strategy, Inc. is headquartered in United States.
Does 0JW9.L pay a dividend?
Lite Strategy, Inc. (0JW9.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0JW9.L go public?
Lite Strategy, Inc. (0JW9.L) completed its initial public offering in 2018.